Am. J. Respir. Cell Mol. Biol., Vol 15, No. 6, Dec 1996, 760-770.
Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages
S Zimmerli, S Edwards and JD Ernst
Division of Infectious Diseases, University of California, San Francisco 94143-0868, USA.
Mycobacterium tuberculosis survives and replicates within human
macrophages, but the mechanisms whereby tubercle bacilli resist killing are
incompletely understood. We tested the general model in which M.
tuberculosis evades killing by entering naive macrophages through receptors
that are unable to activate cellular microbicidal activities. Complement
receptor types 1 (CR1), 3 (CR3), and 4 (CR4) were blocked with monoclonal
antibodies, and mannose receptors were blocked with a competitive ligand,
mannosylated bovine serum albumin (MBSA). Survival and replication of M.
tuberculosis (Erdman) were evaluated after the bacteria were phagocytosed
in the presence of blocking agents (directing binding to the unblocked
receptors). Although there was significant variation in the growth rate of
virulent M. tuberculosis in monocyte-derived macrophages from different
donors, the intracellular survival and replication of mycobacteria were
equivalent regardless of the receptor(s) used for binding and phagocytosis.
We conclude that the mechanisms whereby M. tuberculosis evades killing by
human macrophages are independent of the receptor-mediated route of entry,
and operate at one or more steps common to all entry pathways. Blocking
complement and mannose receptors in combination did not completely abrogate
binding of M. tuberculosis to macrophages. However, we found that two
polyanionic scavenger-receptor ligands exhibited a concentration-dependent
ability to block binding of M. tuberculosis to macrophages. Moreover,
blocking class A scavenger receptors abrogated nearly all binding that
persisted after blocking complement and mannose receptors. This indicates
that class A scavenger receptors are quantitatively important mediators of
M. tuberculosis-macrophage interactions. M. tuberculosis has evolved
multiple mechanisms to promote its efficient entry into macrophages. This
suggests that passage of the organism through macrophages may be an
essential early step in the pathogenesis of tuberculosis.
This article has been cited by other articles:

|
 |

|
 |
 
H. Barth, E. K. Schnober, C. Neumann-Haefelin, C. Thumann, M. B. Zeisel, H. M. Diepolder, Z. Hu, T. J. Liang, H. E. Blum, R. Thimme, et al.
Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells
J. Virol.,
April 1, 2008;
82(7):
3466 - 3479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Vachon, R. Martin, V. Kwok, V. Cherepanov, C.-W. Chow, C. M. Doerschuk, J. Plumb, S. Grinstein, and G. P. Downey
CD44-mediated phagocytosis induces inside-out activation of complement receptor-3 in murine macrophages
Blood,
December 15, 2007;
110(13):
4492 - 4502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Huynh and S. Grinstein
Regulation of Vacuolar pH and Its Modulation by Some Microbial Species
Microbiol. Mol. Biol. Rev.,
September 1, 2007;
71(3):
452 - 462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ben Nasr, J. Haithcoat, J. E. Masterson, J. S. Gunn, T. Eaves-Pyles, and G. R. Klimpel
Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria
J. Leukoc. Biol.,
October 1, 2006;
80(4):
774 - 786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Schulert and L.-A. H. Allen
Differential infection of mononuclear phagocytes by Francisella tularensis: role of the macrophage mannose receptor
J. Leukoc. Biol.,
September 1, 2006;
80(3):
563 - 571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Torres, L. Ramachandra, R. E. Rojas, K. Bobadilla, J. Thomas, D. H. Canaday, C. V. Harding, and W. H. Boom
Role of Phagosomes and Major Histocompatibility Complex Class II (MHC-II) Compartment in MHC-II Antigen Processing of Mycobacterium tuberculosis in Human Macrophages
Infect. Immun.,
March 1, 2006;
74(3):
1621 - 1630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shi, A. Blumenthal, C. M. Hickey, S. Gandotra, D. Levy, and S. Ehrt
Expression of Many Immunologically Important Genes in Mycobacterium tuberculosis-Infected Macrophages Is Independent of Both TLR2 and TLR4 but Dependent on IFN-{alpha}{beta} Receptor and STAT1
J. Immunol.,
September 1, 2005;
175(5):
3318 - 3328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Philips, E. J. Rubin, and N. Perrimon
Drosophila RNAi Screen Reveals CD36 Family Member Required for Mycobacterial Infection
Science,
August 19, 2005;
309(5738):
1251 - 1253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Randhawa, H. J. Ziltener, J. S. Merzaban, and R. W. Stokes
CD43 Is Required for Optimal Growth Inhibition of Mycobacterium tuberculosis in Macrophages and in Mice
J. Immunol.,
August 1, 2005;
175(3):
1805 - 1812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Le Cabec, L. J. Emorine, I. Toesca, C. Cougoule, and I. Maridonneau-Parini
The human macrophage mannose receptor is not a professional phagocytic receptor
J. Leukoc. Biol.,
June 1, 2005;
77(6):
934 - 943.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Villeneuve, M. Gilleron, I. Maridonneau-Parini, M. Daffe, C. Astarie-Dequeker, and G. Etienne
Mycobacteria use their surface-exposed glycolipids to infect human macrophages through a receptor-dependent process
J. Lipid Res.,
March 1, 2005;
46(3):
475 - 483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Aleman, P. Schierloh, S. S. de la Barrera, R. M. Musella, M. A. Saab, M. Baldini, E. Abbate, and M. C. Sasiain
Mycobacterium tuberculosis Triggers Apoptosis in Peripheral Neutrophils Involving Toll-Like Receptor 2 and p38 Mitogen Protein Kinase in Tuberculosis Patients
Infect. Immun.,
September 1, 2004;
72(9):
5150 - 5158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kudo, H. Sano#, H. Takahashi, K. Kuronuma, S.-i. Yokota, N. Fujii, K.-i. Shimada, I. Yano, Y. Kumazawa, D. R. Voelker, et al.
Pulmonary Collectins Enhance Phagocytosis of Mycobacterium avium through Increased Activity of Mannose Receptor
J. Immunol.,
June 15, 2004;
172(12):
7592 - 7602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Villeneuve, G. Etienne, V. Abadie, H. Montrozier, C. Bordier, F. Laval, M. Daffe, I. Maridonneau-Parini, and C. Astarie-Dequeker
Surface-exposed Glycopeptidolipids of Mycobacterium smegmatis Specifically Inhibit the Phagocytosis of Mycobacteria by Human Macrophages: IDENTIFICATION OF A NOVEL FAMILY OF GLYCOPEPTIDOLIPIDS
J. Biol. Chem.,
December 19, 2003;
278(51):
51291 - 51300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. DesJardin, T. M. Kaufman, B. Potts, B. Kutzbach, H. Yi, and L. S. Schlesinger
Mycobacterium tuberculosis-infected human macrophages exhibit enhanced cellular adhesion with increased expression of LFA-1 and ICAM-1 and reduced expression and/or function of complement receptors, Fc{gamma}RII and the mannose receptor
Microbiology,
October 1, 2002;
148(10):
3161 - 3171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Le Cabec, S. Carreno, A. Moisand, C. Bordier, and I. Maridonneau-Parini
Complement Receptor 3 (CD11b/CD18) Mediates Type I and Type II Phagocytosis During Nonopsonic and Opsonic Phagocytosis, Respectively
J. Immunol.,
August 15, 2002;
169(4):
2003 - 2009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. van Crevel, T. H. M. Ottenhoff, and J. W. M. van der Meer
Innate Immunity to Mycobacterium tuberculosis
Clin. Microbiol. Rev.,
April 1, 2002;
15(2):
294 - 309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S B Gordon and R C Read
Macrophage defences against respiratory tract infections: The immunology of childhood respiratory infections
Br. Med. Bull.,
March 1, 2002;
61(1):
45 - 61.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hu, T. Mayadas-Norton, K. Tanaka, J. Chan, and P. Salgame
Mycobacterium tuberculosis Infection in Complement Receptor 3-Deficient Mice
J. Immunol.,
September 1, 2000;
165(5):
2596 - 2602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Le Cabec, C. Cols, and I. Maridonneau-Parini
Nonopsonic Phagocytosis of Zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) Involves Distinct Molecular Determinants and Is or Is Not Coupled with NADPH Oxidase Activation
Infect. Immun.,
August 1, 2000;
68(8):
4736 - 4745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Terpstra, E. S. van Amersfoort, A. G. van Velzen, J. Kuiper, and T. J. C. van Berkel
Hepatic and Extrahepatic Scavenger Receptors : Function in Relation to Disease
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2000;
20(8):
1860 - 1872.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. A. Malik, G. M. Denning, and D. J. Kusner
Inhibition of Ca2+ Signaling by Mycobacterium tuberculosis Is Associated with Reduced Phagosome-Lysosome Fusion and Increased Survival within Human Macrophages
J. Exp. Med.,
January 17, 2000;
191(2):
287 - 302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Thomas, Y. Li, T. Kodama, H. Suzuki, S. C. Silverstein, and J. El Khoury
Protection from Lethal Gram-positive Infection by Macrophage Scavenger Receptor-dependent Phagocytosis
J. Exp. Med.,
January 3, 2000;
191(1):
147 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Jagannath, M. R. Emanuele, and R. L. Hunter
Activities of Poloxamer CRL-1072 against Mycobacterium avium in Macrophage Culture and in Mice
Antimicrob. Agents Chemother.,
December 1, 1999;
43(12):
2898 - 2903.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Capo, F. P. Lindberg, S. Meconi, Y. Zaffran, G. Tardei, E. J. Brown, D. Raoult, and J.-L. Mege
Subversion of Monocyte Functions by Coxiella burnetii: Impairment of the Cross-Talk Between {alpha}v{beta}3 Integrin and CR3
J. Immunol.,
December 1, 1999;
163(11):
6078 - 6085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-M. Ting, A. C. Kim, A. Cattamanchi, and J. D. Ernst
Mycobacterium tuberculosis Inhibits IFN-{gamma} Transcriptional Responses Without Inhibiting Activation of STAT1
J. Immunol.,
October 1, 1999;
163(7):
3898 - 3906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. Means, S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton
Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis
J. Immunol.,
October 1, 1999;
163(7):
3920 - 3927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Bermudez, J. Goodman, and M. Petrofsky
Role of Complement Receptors in Uptake of Mycobacterium avium by Macrophages In Vivo: Evidence from Studies Using CD18-Deficient Mice
Infect. Immun.,
September 1, 1999;
67(9):
4912 - 4916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zabaleta, M. Arias, J. R. Maya, and L. F. García
Diminished Adherence and/or Ingestion of Virulent Mycobacterium tuberculosis by Monocyte-Derived Macrophages from Patients with Tuberculosis
Clin. Vaccine Immunol.,
September 1, 1998;
5(5):
690 - 694.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. ASTON, W. N. ROM, A. T. TALBOT, and J. REIBMAN
Early Inhibition of Mycobacterial Growth by Human Alveolar Macrophages is not Due to Nitric Oxide
Am. J. Respir. Crit. Care Med.,
June 1, 1998;
157(6):
1943 - 1950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Ernst
Macrophage Receptors for Mycobacterium tuberculosis
Infect. Immun.,
April 1, 1998;
66(4):
1277 - 1281.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. W. SCHLUGER and W. N. ROM
The Host Immune Response to Tuberculosis
Am. J. Respir. Crit. Care Med.,
March 1, 1998;
157(3):
679 - 691.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bernardo, A. M. Billingslea, R. L. Blumenthal, K. F. Seetoo, E. R. Simons, and M. J. Fenton
Differential Responses of Human Mononuclear Phagocytes to Mycobacterial Lipoarabinomannans: Role of CD14 and the Mannose Receptor
Infect. Immun.,
January 1, 1998;
66(1):
28 - 35.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 American Thoracic Society.
|
|
|